Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-24

FDA Approved: CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION — Supplemental Application (Bajaj Medical, LLC)

View source ↗

Summary

FDA approved a supplemental application for Bajaj Medical, LLC to market chlorhexidine gluconate 0.12% oral rinse solution under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine Gluconate 0.12% Oral Rinse Solution (Chlorhexidine gluconate 0.12% oral rinse solution)

Snippet

SUPPL AP for CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION (CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION)